Argenx to participate at upcoming investor conferences

November 5, 2024 amsterdam, the netherlands – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of the management team will participate in the following upcoming investor conferences in november:

ARGX Ratings Summary

ARGX Quant Ranking